...
首页> 外文期刊>Neurology: Official Journal of the American Academy of Neurology >Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.
【24h】

Dominant perivenular enhancement of tumefactive demyelinating lesions in multiple sclerosis.

机译:主导perivenular块状。簇状增强脱髓鞘病变的多发性硬化症。

获取原文
获取原文并翻译 | 示例
           

摘要

A 51-year-old woman presented with aphasia and bifrontal MRI lesions with punctuate and vague linear enhancement (figure). She improved spontaneously but 4 months later deteriorated due to the large mass and required cranial decompression. Innumerable, perivenular enhancements perpendicular to the lateral ventricles were seen within extensive bihemispheric white matter lesions. Multiple sclerosis (MS) was diagnosed based on typical inflammatory demyelination at biopsy, CSF oligoclonal bands, and a previous CNS event. Treatment with mitoxantrone and Copaxone followed. MRI lesions improved rapidly. She remains stable with minimal deficit (Expanded Disability Status Scale 1.0) 2 years later. Dominant perivenular enhancements are atypical for MS1'2 but deserve recognition, although they may not prevent biopsy.
机译:一位51岁的女人和失语症bifrontal MRI病灶加标点和模糊线性增强(图)。自发但4个月后由于恶化所需的大质量和颅减压。增强垂直于外侧心室中被广泛bihemispheric白质病变。基于典型硬化症(MS)被诊断炎性脱髓鞘活检,CSF寡克隆条带,前一个中枢神经系统活动。米托蒽醌治疗和Copaxone紧随其后。保持稳定的赤字(扩大残疾状态规模1.0)2年后。主导perivenular增强非典型为MS1 2但应得的认可,尽管他们可能不会阻止活检。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号